Day: March 14, 2022

March 14, 2022

Philips advances precision care with new releases of HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge  

Amsterdam, the Netherlands and Orlando, Florida, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its latest introductions in analytics and interoperability solutions at the HIMSS22 Global Health Conference & Exhibition. Philips HealthSuite Interoperability is a fully integrated cloud-enabled Health IT platform to meet diverse workflow needs across the imaging enterprise. Philips Enterprise Performance Analytics – Performance Bridge – now provides operational insights and deep analytics beyond radiology to the cardiology department to enhance efficiencies and help improve effectiveness at the point of care. Both innovations are part of Philips’ Data Management and Interoperability Solutions portfolio [1], an integrated, scalable suite of innovative technology, analytics and professional services, designed to support healthcare providers to continuously improve performance.

“Building on our deep expertise in medical imaging and insights in enterprise informatics, this latest expansion of our Data Management and Interoperability Solutions portfolio will help drive sustainable change across imaging departments with enhanced efficiency and improved outcomes for patients and staff,” said Kees Wesdorp, Chief Business Leader of Precision Diagnosis at Philips. “At HIMSS, we will showcase a highly-customizable set of data-driven solutions, delivering continuous improvement to meet clinical and business performance metrics with real-time insights.”

Advancing precision care with integrated data for meaningful insights
Every second, an exponential amount of healthcare data is generated and mined for valuable insights. Today, approximately 30% of the world’s data volume is being generated by the healthcare industry [2]. Successfully integrating healthcare data is complicated, with multiple user interfaces, complex systems and the slow retrieval of clinically relevant information, all of which hamper workflow efficiency and delay precision care. These challenges have been further exacerbated by COVID-19. At HIMSS, Philips will present how the company’s new Data Management and Interoperability Solutions portfolio is designed to enhance care planning and coordination with clinical and operational analytics to help improve workflow efficiency, patient and staff satisfaction and outcomes.

Vendor-neutral solutions support data from imaging modalities on a common platform
The Data Management and Interoperability Solutions portfolio features two critical components. At HIMSS, Philips will spotlight HealthSuite Interoperability, a fully integrated cloud-enabled health IT platform to meet diverse workflow needs across the imaging enterprise, connecting third-party systems and enabling seamless data workflows to streamline efficiency. This newest version of HealthSuite Interoperability will enable Philips to deliver integrated informatics solutions to help improve clinical workflow, enhance patient care and optimize enterprise management.

The platform will support all relevant data types and formats including DICOM (Digital Imaging and Communications in Medicine) images, genomics, pathology, laboratory data, HL7 (Health Level Seven International) standards, formats and definitions for exchanging and developing electronic health records messages, and FHIR (Fast Healthcare Interoperability Resources) standards. HealthSuite Interoperability will also support all major Electronic Medical Records (EMRs) vendors. Its clinical data repository also offers customers the ability to store and manage granular data, and can be used to create value driving solutions like health image exchanges.

Expanding beyond radiology to feature new cardiology analytics to enhance workflow
Philips’ Data Management and Interoperability Solutions also features the company’s newest enhancements in Enterprise Performance Analytics – Performance Bridge – expanding operational insights and deep analytics beyond radiology to the cardiology department to enhance efficiencies and help improve effectiveness at the point of care. Philips Enterprise Performance Analytics – Performance Bridge – gives healthcare professionals access to near real-time data on departmental performance through an easy-to-use interactive dashboard. Its operational insights have driven performance improvements in multiple health systems including Miami Cardiac and Vascular Institute, where 100% of staff surveyed stated the Performance Bridge Patient Flow applications saves time in their workday and improves teamwork and communication [3]. Additionally, Kootenai Health in Idaho has leveraged the near real-time insights of Performance Bridge to improve their Cath Lab operations. Within 3 years, they have documented an increase in radial access rates associated with fewer complications, including major bleeding and mortality, from 9% to 42%, while improving patient comfort and shortening recovery times [4].

With these newest enhancements, cardiology departments now have access to critical metrics to support operational performance monitoring in an invasive procedural setting such as the interventional suite, providing data on procedure volumes, room utilization, procedure duration and lab turnaround time.

Cardiology departments can also access key metrics designed to support operational performance monitoring in a non-invasive procedural setting such as cardiac imaging suites, most notably echocardiography, with access to data on procedure volumes, modality/machine utilization, study type counts and report turnaround time. This newest release further demonstrates Philips’ commitment to bring together the right combination of services and tools to measure and monitor key areas of improvement to help drive continuous improvement in radiology and cardiology departments to optimize operations, enhance workflow efficiencies and improve patient outcomes.

For more information on Philips’ full portfolio of connected informatics solutions being showcased in Booth #2501 at the HIMSS22 Global Health Conference & Exhibition, please visit www.philips.com/himss and follow @PhilipsLiveFrom for #HIMSS22 updates throughout the event.

[1] Pending 510(k) approval and not available for sale. For demonstration purposes only.
[2] https://www.rbccm.com/en/gib/healthcare/episode/the_healthcare_data_explosion.
[3] Patient Flow at MCVI: Interview Survey of Employees, Nov. 2021.
[4] Kootenai Health and Philips beta testing co-creation project, results tabulation from 2018-2021.

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978 221 8919
E-mail: kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Clinicians presenting performance data
• Clinicians discussing performance data
• Clinician reviewing performance data

• Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at night
• Quality and quantity of sleep have benefitted from remote working, and many are concerned waking up will be difficult as they return to a physical workplace
• More than half of Americans report their doctor hasn’t asked them about their sleep health

SAN DIEGO, March 14, 2022 (GLOBE NEWSWIRE) — ResMed announced today the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,¹ asked nearly 25,000 respondents in 12 countries what’s keeping them up at night and the results aim to build awareness of the critical role good sleep plays in physical and mental health.

Across most countries, a majority of respondents reported stress has had an impact on their sleep since the start of the pandemic, with a high of 64% in Brazil and a low of 35% in Germany and Japan. In the United States, 38% of respondents cited depression and anxiety as the reasons they do not sleep well at night. Beyond stress, depression, and anxiety, respondents listed family pressures, work-related concerns, and financial pressures as reasons for not sleeping well.

The survey also revealed how returning to the office has impacted the way people believe their sleep quality will change. Many respondents said they have slept better or longer while working remotely and believe more in-office working time will make it difficult to wake up in the morning:

• 45% of Americans who reported working from home said they get more sleep compared to working in an office, and 48% of those who said they currently work remotely said it will be harder for them to wake up once they return to a physical workplace.
• Germany (66%), India (65%), China (61%), and Australia (60%) ranked highest in respondents who reported working from home and predicted it will be harder for them to get up in the morning once they transition back to working in an office.

“Getting good quality sleep is a struggle for people across the globe for many different reasons,” said Carlos M. Nunez, M.D., chief medical officer for ResMed. “It is clear that the pandemic has caused an increase in poor quality sleep due to stress, depression, and anxiety, but our survey found that in most countries, nearly half of respondents say they’ve never sought professional medical help to improve their sleep or address underlying issues.”

Sleep Aids and Medications
While sleep health is an important issue, many survey respondents said they’re not consulting with their doctor on solutions to get a better night’s sleep, but rather turning to potentially unhealthy habits such as:

• Binge-watching television shows to help them fall asleep (23% of Americans, 20% of Germans and British respondents); or
• Traditional medications or alternative sleep aids such as aromatherapy or tea (29% of Americans).

More than half of Americans say their doctor has never proactively asked them about the quality of their sleep – and that number is even higher across the globe.

Snoring and Sleep Conditions
While everyone experiences a lousy night of sleep occasionally, those who experience ongoing sleep issues could be dealing with a more significant underlying health condition. Approximately 52% of Americans reported snoring or being told they snore, but only 33% are concerned about health implications tied to snoring. People may think they are sleeping soundly when in fact, they are repeatedly and unconsciously waking up throughout the night due to undiagnosed sleep apnea – of which snoring is the number one symptom.

“Sleep quality can be impacted by lifestyle changes and poor habits, but many people are struggling with undiagnosed conditions that may be the root cause,” said Carlos M. Nunez, M.D. “Sleep apnea is a serious health concern, but very few people are screened for the condition which impacts more than 54 million people in the U.S.”²

In America, only 22% of respondents said they have been tested for sleep apnea. That percentage is even lower in other countries: 17% testing in France, 15% in Germany, 13% in the United Kingdom, and 12% in Singapore.

To learn more about the state of sleep health across the globe and sleep apnea, or to take a quick self-assessment for your risk of sleep apnea, visit SleepForBetterTomorrow.com.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

1 ResMed 2022 Global Surveys, 23,040 total participants across Australia, Brazil, China, France, Germany, India, Japan, Mexico, Singapore, South Korea, United Kingdom, and United States, conducted from January 19 to February 18, 2022.
2 Benjafield AV et al. Lancet Resp Med 2019

March 14, 2022

• Flexible, secure, cloud-based Philips HealthSuite solutions and innovative business models aim to connect care across settings, address workforce challenges, drive efficiency and improve outcomes
• Informatics solutions provide deep insights at the points-of-care in acute, ambulatory, and interventional settings, and beyond to simplify care orchestration for providers and help improve patient outcomes and experience

Amsterdam, the Netherlands and Orlando, Florida, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest secure, connected and scalable informatics solutions during the HIMSS22 Global Health Conference & Exhibition. Philips will share its deep clinical and operational expertise to support healthcare providers’ digital transformations and showcase its informatics suite that delivers data-driven actionable insights to advance precision care, support care along each patient’s pathway and improve transitions across care settings. Philips will spotlight how its integrated solutions address some of the most urgent needs that the industry faces today, including staff shortages and cybersecurity threats.

As care settings extend beyond the hospital, with increasing ambulatory and home care, the health IT landscape is growing accordingly. Health systems are seeking ways to improve patient and provider experiences and better deliver care throughout the continuum by connecting data from various points-of-care and disparate systems. Cloud-based, integrated platforms are increasingly recognized for their ability to liberate data from siloes and derive meaningful insights that support workflows enabling precise, proactive and integrated care delivery. With HealthSuite at its center, Philips brings a secure, interoperable and future-ready informatics platform that integrates live-streaming, high-fidelity data with contextual decision support, presenting actionable insights for individual patients and at scale.

“Digital transformation and a faster adoption of digital technologies is possible, as we have seen during the COVID-19 pandemic. How we partner with our customers to serve their evolving needs across operations and patient care is more essential than ever, especially as healthcare organizations face many challenges – from staffing shortages, to security challenges, to gaps in patient care” said Roy Jakobs, Chief Business Leader Connected Care, Philips. “We aim to be the caregiver’s trusted partner, by providing a secure backbone, revealing patient insights at the point-of-care and beyond, to help drive confident clinical and operational decision making as part of their ecosystem. We are with our customers at every step of innovation to streamline workflows, accelerate diagnosis and treatment, and optimize patient and staff experiences.”

Industry recognition
Philips’ commitment to empowering clinicians with meaningful innovation and actionable insights is evident in its latest accolades. Most recently, the purpose-built, cloud-based Philips HealthSuite Platform, which serves as the foundation of Philips’ informatics innovation, was recognized in the 2021 Gartner® Market Guide for Digital Health Platforms. Additionally, Philips received two ‘Best in KLAS’ awards from KLAS Research for Philips Enterprise Viewer – Vue Motion – and Philips EMR Tasy electronic medical record.

Advancing care pathways across the continuum
Visitors to the Philips Booth (#2501) at HIMSS will experience a full suite of integrated informatics solutions, ranging from emergency care, to precision diagnosis, to ambulatory and home care, with a focus on integrated solutions across the following key care pathways:

Ambulatory Cardiac Care: Philips’ portfolio of cardiology solutions can help make care delivery accurate, comprehensive and efficient, with clinically validated ambulatory cardiac diagnostics, monitoring services and a cardiac data platform that integrates data from almost any remote cardiac monitoring device. In a recent example, Philips announced the results of a study [1] that found 30-days of a continuous monitoring program using Philips BioTel Heart MCOT patch improved atrial fibrillation detection rates among post-cryptogenic stroke patients, while minimizing cost and reducing the risk of secondary stroke.

Integrated Diagnostics: Philips HealthSuite Interoperability is a fully integrated cloud-enabled Health IT platform that meets diverse workflow needs across the imaging enterprise, enabling better integration of imaging and related data across various clinical service lines. Philips Enterprise Performance Analytics – PerformanceBridge – will provide real-time insights in utilization and clinical operations in radiology and cardiology to help better leverage the workforce, enhance efficiencies and improve care delivery and patient experience. Both innovations are part of Philips Data Management and Interoperability Solutions [2], an integrated, scalable portfolio of innovative technologies, analytics and professional services, designed to support healthcare providers to continuously improve performance. Philips will also highlight its market leading Enterprise Imaging solutions and the emerging clinical applications on that platform as it helps health systems to accelerate in their progress along the HIMSS Digital Imaging Adoption Model (DIAM).

Acute Patient Management: Philips’ acute patient management solutions help accelerate diagnosis and treatment, identify changes through precise and continuous patient monitoring and help provide accurate and predictive surveillance based on multi device and systems patient data so caregivers can provide a timely response with confidence. In defining moments and throughout the patient journey, Philips aims to extend the sight and reach of providers across settings and through transitions to orchestrate better patient experiences, effective care management and optimal outcomes.

Philips at HIMSS22
Visitors to Philips’ booth will be able to participate in two immersive experiences that showcase Philips’ connected care approach from pre-hospital to post-discharge, one in which they follow an arrythmia patient’s end-to-end connected care journey, and one highlighting the experience of a patient in critical condition.

Throughout the week, Philips will also spotlight news regarding the latest release of Philips Capsule Surveillance solution, as well as an update on Philips’ cybersecurity services. Philips will also host Philips Live! Forum sessions in its booth, featuring presentations from Philips executives, customers and industry leaders discussing the latest topics in health informatics including remote patient monitoring, virtual care, precision diagnostics, AI, interoperability, cybersecurity, cloud innovation and more. Philips thought leaders will also participate in various HIMSS executive sessions roundtables, general education and industry solution sessions. A complete list of presenters, topics, dates and times is available here.

For more information on Philips’ full portfolio of informatics solutions being showcased in Booth #2501 at the HIMSS22 Global Health Conference & Exhibition, taking place from March 14-18 in Orlando, FL, please visit www.philips.com/himss and follow @PhilipsLiveFrom for #HIMSS22 updates throughout the event.

[1] Medic G, Kotsopoulos N, Connolly MP, Lavelle J, Norlock V, Wadhwa M, Mohr BA, Derkac WM. Mobile Cardiac Outpatient Telemetry Patch vs Implantable Loop Recorder in Cryptogenic Stroke Patients in the US – Cost-Minimization Model. Med Devices (Auckl). 2021 Dec 18;14:445-458. doi: 10.2147/MDER.S337142. PMID: 34955658; PMCID: PMC8694406. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694406/

[2] Pending 510(k) approval and not available for sale. For demonstration purposes only.

For further information, please contact:
Anna Hogrebe
Philips Global Press Office
Tel.: +1 416 270 67 57
E-mail: anna.hogrebe@philips.com

Kathy O’Reilly
Philips Group Press Office
Tel.: +1 978 221 8919
E-mail: kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Patient Flow Solution
• Clinician at Bedside
• PerformanceBridge
• Patient wearing MCOT at home

MONTREAL, March 14, 2022 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (“BRW” or the “Company”) is pleased to announce that it has staked multiple claim groups in central New Brunswick, totaling 42,737 hectares. The Properties collectively comprise an expansion to the Catamaran claims (see press release dated December 2^nd) located roughly 30 kilometers southeast of Plaster Rock and the Hawkshaw claims located roughly 24 kilometers northwest of Fredericton.

Mr. Killian Charles, President of BRW, commented: “We have now compiled and acquired the most prospective lithium and tin targets across Quebec and New Brunswick. BRW is one of the only companies to assemble regional, grass roots critical metals projects across multiple safe jurisdictions in Eastern Canada. Phase 1 prospecting along with soil/stream geochemical sampling will begin in Q2 2022. We are thrilled to have secured such a prospective portfolio and look forward to expanding it further in order to discover new mineral deposits that will meet the needs of the rapidly developing green economy.”

Compilation work utilized specific geological criteria as well as regional government till and rock geochemistry data, which allowed the Company to highlight previously ignored pegmatite fields with high potential for lithium mineralization within geologically favourable areas in New Brunswick.

New Brunswick – Catamaran Lithium Project Overview

The Properties comprise 8 claims and 1,821 units with a total surface area of 40,363 hectares. They are located roughly 30 kilometers south east of Plaster Rock and roughly 30 kilometers east of Florenceville-Bristol. Including previously staked ground, the property is host to over 60 pegmatites that have seen little to no exploration work. Till samples collected by the Government of New Brunswick were taken at roughly 2-kilometer spacing and are underlain by pegmatitic granites and gneissic to migmatitic sediments from the Devonian and Ordovician. Highlights from the survey include an 11-kilometer till anomaly containing 9 samples between 53 to 103 ppm Li, neighboring known beryllium and pegmatite occurrences.

New Brunswick – Hawkshaw Lithium Project Overview

The Properties comprise 1 claim and 106 units with a total surface area of 2,374 hectares. They are located roughly 24 kilometers north west of Fredericton. Government of New Brunswick till samples were taken at roughly 2-kilometer spacing and are underlain by sediments and granites from the Devonian and Silurian. There is a Be, Mo, W occurrence in close proximity to the property and highlights from the survey include 90 and 155 ppm Li in till.

Qualified Person

The scientific and technical information contained in this press release has been reviewed and approved by Mr. Charles Kodors, Manager New Brunswick of Brunswick Exploration. He is a Profession Geologist registered in New Brunswick, Nova Scotia and Quebec.

About Brunswick Exploration

The Company is a Montreal-based mineral exploration venture listed on the TSX-V under symbol BRW. The Company is focused on grassroot exploration for metals necessary to decarbonization and energy transition with a particular focus on lithium, tin and copper. The company is focused on rapidly advancing the most extensive grassroot lithium exploration claim package in Eastern Canada.

Investor Relations/information

Mr. Killian Charles, President (info@BRWexplo.com).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Cautionary Statement on Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets; inflation; fluctuations in commodity prices; delays in the development of projects; the other risks involved in the mineral exploration and development industry; and those risks set out in the Corporation’s public documents filed on SEDAR at www.sedar.com. Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

โตรอนโต, March 14, 2022 (GLOBE NEWSWIRE) — Sophi.ioแพลตฟอร์มระบบอัตโนมัติและการเพิ่มประสิทธิภาพที่ขับเคลื่อนด้วย AI ของ The Globe and Mail ได้รับการประกาศในสัปดาห์นี้ในฐานะผู้ที่ผ่านเข้ารอบสุดท้ายในรางวัล 2022 Global Media Awards ของ International News Media Association (INMA) ในประเภทนวัตกรรมที่ดีที่สุดในการเปลี่ยนแปลงห้องแถลงข่าว ระบบนี้ช่วยในการจัดวางการพิมพ์แบบอัตโนมัติให้กับ Agderposten ซึ่งเป็นหนังสือพิมพ์รายวันระดับภูมิภาคที่ให้บริการผู้อ่านกว่า 25,000 คนทั่วนอร์เวย์ และให้ประสิทธิภาพการพิมพ์เพิ่มขึ้น 66% โดยได้มีการร่วมมือกับ Naviga อีกด้วย

Gordon Edall ผู้ก่อตั้งร่วมของ Sophi.io กล่าวว่า“ระบบแมชชีนเลิร์นนิงอัตโนมัติของ Sophi เป็นการเปลี่ยนแปลงครั้งใหญ่ที่สุดของสื่อสิ่งพิมพ์ในรอบหลายทศวรรษนี้” “เรารู้สึกขอบคุณที่ Agderposten เลือกที่จะทำงานกับ Naviga และกับเรา ความมุ่งมั่นของพวกเขาในการปรับปรุงประสิทธิภาพและโอบรับเทคโนโลยีที่ก้าวล้ำดังเช่น Naviga Publisher ที่ขับเคลื่อนโดย Sophi.io น่าจะสร้างแรงบันดาลใจให้อุตสาหกรรมสื่อทั้งหมดในการตั้งตารออนาคตที่ AI และระบบอัตโนมัติจะสามารถช่วยเหลือทุกคนได้”

Naviga Publisher ซึ่งขับเคลื่อนโดย Sophi.io เป็นระบบที่ขับเคลื่อนด้วยปัญญาประดิษฐ์ที่เลียนแบบการตัดสินใจของมนุษย์ในการที่จะผลิตหน้าหนังสือพิมพ์ที่ดูเหมือนได้รับการสร้างขึ้นด้วยความเข้าใจในข่าวประจำวันรวมถึงมาตรฐานระดับสูงของนักข่าว สิ่งที่บรรณาธิการต้องทำนั้นมีเพียงแค่จัดลำดับความสำคัญของบทความและกดปุ่ม “พิมพ์หนังสือพิมพ์ของฉัน” เพื่อสร้างการจัดวางการพิมพ์อัตโนมัติ โดยไม่ต้องใช้เทมเพลต และใช้เวลาเพียงแค่ไม่กี่นาทีเท่านั้น การช่วยจัดการงานที่ต้องใช้แรงงานอย่างมากนี้ทำให้ห้องแถลงข่าวสามารถมุ่งเน้นไปที่วัตถุประสงค์ที่แท้จริงของพวกเขาในการค้นหาและบอกเล่าเรื่องราวที่สำคัญเรื่องต่อไปได้

Katrine Lia บรรณาธิการบริหารของ Agderposten กล่าวว่า “มันช่วยประหยัดเวลาในการทำข่าวไปได้หลายชั่วโมงเลยทีเดียว” และพนักงานที่ Agderposten มักจะไม่สามารถบอกถึงความแตกต่างระหว่างหน้าที่จัดทำโดย Sophi กับหน้าที่จัดทำโดยบรรณาธิการของพวกเขาได้เลย

Sophi และ Naviga ซึงเป็นผู้ให้บริการเทคโนโลยีซอฟต์แวร์รายใหญ่สำหรับอุตสาหกรรมสิ่งพิมพ์ทั่วโลกนั้น ได้ร่วมงานกับ Agderposten มานานกว่าหนึ่งปีแล้ว และความสำเร็จเหล่านี้ก็ได้ปูทางไปสู่การนำหัวเรื่องใหม่ ๆ หลายสิบเรื่องจากบริษัทสิ่งพิมพ์ใหญ่ ๆ หลายแห่งมาเข้าร่วมในปีนี้ Sophi นำเสนอเทคโนโลยี AI และ ML ที่ล้ำสมัยควบคู่ไปกับ Naviga Publisher ทำให้เวิร์กโฟลว์การผลิตงานพิมพ์ตั้งแต่ต้นจนจบนั้นเป็นระบบอัตโนมัติได้อย่างสมบูรณ์

Agderposten เป็นลูกค้ารายแรกที่ใช้ Publisher ขณะนี้กระบวนการผลิตงานพิมพ์ได้รับการรวมศูนย์ การจัดวางหนังสือพิมพ์เป็นแบบอัตโนมัติถึง 80% และสิ่งที่น่าประทับใจที่สุดก็คือ Agderposten ได้ตระหนักรู้ในเรื่องของการใช้เวลาและทรัพยากรที่ใช้ว่ามีการลดลงถึง 66% ซึ่งช่วยลดต้นทุนการผลิตหนังสือพิมพ์และให้นักข่าวทำงานเพื่อสร้างเนื้อหาดิจิทัล มากกว่าการที่ต้องมาใช้งาน InDesign

Øyvind Klausen ซีอีโอของ Agderposten ได้กล่าวว่า เขาคาดว่าการประหยัดต้นทุนและประสิทธิภาพจะเพิ่มขึ้นอย่างต่อเนื่อง อันเนื่องมาการที่จากหน้าเว็บของ Agderposten นั้นเป็นรูปแบบอัตโนมัติมากขึ้น และหนังสือพิมพ์ของบริษัทก็ได้ใช้โซลูชันการพิมพ์แบบอัตโนมัติมากขึ้นนั่นเอง

ในปีนี้นั้น Global Media Awards ได้มีผู้เข้าร่วมแข่งขันจำนวน 854 รายจาก 252 แบรนด์ข่าวใน 46 ประเทศ ผู้ตัดสินประกอบด้วยผู้เชี่ยวชาญด้านสื่อ 50 คนจาก 24 ประเทศใน 20 หมวดหมู่ โดยรวมถึงแบรนด์ข่าว แพลตฟอร์มสื่อ การสมัครรับข้อมูล การโฆษณา ข้อมูลและข้อมูลเชิงลึก ผลิตภัณฑ์ และห้องแถลงข่าว โดยจะมีการประกาศผู้ชนะอันดับหนึ่งในวันที่ 9 มิถุนายน

เกี่ยวกับ Naviga
Naviga (https://www.navigaglobal.com) เป็นผู้ให้บริการซอฟต์แวร์และบริการชั้นนำในอุตสาหกรรมสื่อที่หลากหลาย แพลตฟอร์มการมีส่วนร่วมในเนื้อหาช่วยให้บริษัทต่าง ๆ สามารถสร้าง เพิ่มคุณค่า ส่งมอบ และสร้างรายได้จากเนื้อหาเพื่อจัดการการมีส่วนร่วมได้อย่างครบวงจร โซลูชันของพวกเขาใช้งานง่าย ปรับขนาดได้ และคล่องตัว พวกเขาได้พัฒนาโซลูชันซอฟต์แวร์ที่ช่วยให้ธุรกิจที่ขับเคลื่อนด้วยเนื้อหาสามารถตอบสนองความต้องการในอนาคตของข้อมูลได้ โดยใช้การผสมผสานประสบการณ์ในด้านสื่อของพวกเขาเข้าด้วยกันกับการอุทิศตนและทุ่มเทให้กับคำว่าดิจิทัล Naviga มีสำนักงานใหญ่อยู่ที่บลูมิงตัน รัฐมินนิโซตา และยังมีสำนักงานภูมิภาคอยู่ทั่วโลก Naviga เป็นพันธมิตรที่เชื่อถือได้ซึ่งให้บริการลูกค้ามากกว่า 1,400 ราย ใน 45 ประเทศ โดยลูกค้าเหล่ามีทั้งสื่อข่าว สื่อบันเทิง การออกอากาศ นิตยสาร บริการทางการเงิน และลูกค้าที่เป็นองค์กรใหญ่ ๆ

เกี่ยวกับ Sophi.io Sophi.io (https://www.sophi.io) ได้รับการพัฒนาขึ้นโดย The Globe and Mail เพื่อช่วยผู้เผยแพร่เนื้อหาในการตัดสินใจเชิงกลยุทธ์และยุทธวิธีที่สำคัญ มันเป็นชุดระบบอัตโนมัติที่ขับเคลื่อนด้วย AI และ ML ซึ่งเป็นโซลูชันการเพิ่มประสิทธิภาพและการคาดการณ์ซึ่งรวมถึง Sophi Site Automation, Sophi for Paywalls และ Sophi for First Party Data นอกจากนี้ Sophi ยังขับเคลื่อน Naviga Publisher สำหรับการจัดรูปแบบสิ่งพิมพ์และการเผยแพร่ ePaper โดยอัตโนมัติในคลิกเดียว Sophi ออกแบบมาเพื่อปรับปรุงเมตริกที่มีความสำคัญต่อธุรกิจของคุณมากที่สุด เช่น การรักษาผู้สมัครสมาชิกและการเข้าซื้อกิจการ การมีส่วนร่วม ความใหม่ ความถี่และปริมาณ

ติดต่อด้านสื่อ
Jamie Rubenovitch
หัวหน้าฝ่ายการตลาด, Sophi
The Globe and Mail
416-585-3355  
jrubenovitch@globeandmail.com